Purdue Pharma denies EY conflicts of interest, fraudulent transfers
Purdue Pharma entered bankruptcy in September facing thousands of lawsuits over the opioid crisis. (Credit: iStock.com/BackyardProduction)
Bankrupt US OxyContin maker Purdue Pharma has denied claims its plan to hire EY would create a conflict of interest, as it fights fraudulent transfer claims raised in the US Supreme Court.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Upgrade now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10